Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis
出版年份 2020 全文链接
标题
Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis
作者
关键词
-
出版物
Journal for ImmunoTherapy of Cancer
Volume 8, Issue 2, Pages e001887
出版商
BMJ
发表日期
2020-12-09
DOI
10.1136/jitc-2020-001887
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tocilizumab for Fulminant Programmed Death 1 Inhibitor–Associated Myocarditis
- (2020) Hanping Wang et al. Journal of Thoracic Oncology
- Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy
- (2020) Brendan L. Mangan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated Myocarditis
- (2020) Lili Zhang et al. CIRCULATION
- Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
- (2020) Joachim Alexandre et al. Journal of the American Heart Association
- Cardiovascular toxicities associated with immune checkpoint inhibitors
- (2019) Jiun-Ruey Hu et al. CARDIOVASCULAR RESEARCH
- Myocarditis in the Setting of Cancer Therapeutics
- (2019) Marc P. Bonaca et al. CIRCULATION
- Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy
- (2019) Khashayar Esfahani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- (2019) Joe-Elie Salem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute Coronary Syndrome With Immune Checkpoint Inhibitors: A Proof-of-Concept Case and Pharmacovigilance Analysis of a Life-Threatening Adverse Event
- (2019) Jennifer Cautela et al. CANADIAN JOURNAL OF CARDIOLOGY
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin
- (2018) Varun Jain et al. JOURNAL OF IMMUNOTHERAPY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
- (2018) Javid J Moslehi et al. LANCET
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation
- (2018) Vanessa M. Ferreira et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- Potential of Oncocardiology
- (2017) Jennifer Cautela et al. JAMA Cardiology
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
- (2015) S. Champiat et al. ANNALS OF ONCOLOGY
- PD-1 is a novel regulator of human B-cell activation
- (2012) Marie-Laure Thibult et al. INTERNATIONAL IMMUNOLOGY
- Myocarditis associated with infliximab
- (2010) Eoin Slattery et al. INFLAMMATORY BOWEL DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started